Blood

923 papers64 directions
Blood is a long-standing publication venue for hematological research, with active contributions in the corpus spanning from 1973 through 2026. In the context of machine learning and artificial intelligence, the venue focuses on the integration of computational methods with clinical hematology to improve patient outcomes. Its content frequently addresses the development of independent biomarkers for disease prognosis, risk stratification for precision treatment selection, and the identification of molecular regulatory axes to overcome chemotherapy resistance. The venue publishes research on the application of AI-based diagnostic tools, such as those used for identifying myelodysplastic syndromes, and the use of integrated profiling to predict treatment responses in conditions like acute myeloid leukemia. Recent papers also explore technical frameworks for data science in medicine, including the generation of synthetic data over federated learning systems to accelerate personalized medicine. This research often utilizes large-scale data sources, such as nationwide electronic health record databases, to conduct epidemiological studies on conditions like venous thromboembolism. In the broader research community, Blood serves as a platform for addressing the statistical and methodological challenges of applying data science to specialized medicine. This includes investigating the generalizability gap in single-center clinical research and managing statistical power challenges in rare disease studies. Prolific contributors such as Zhixiang Shen, Aaron D. Schimmer, and Véronique Voisin highlight the venue's role in bridging bridging strategies for stem cell transplantation with advanced predictive modeling and microvascular visualization techniques.

Papers by Year

2026 4
2025 99
2024 129
2023 83
2022 72
2021 31
2020 44
2019 40
2018 42
2017 17
2016 30
2015 30
2014 26
2013 30
2012 33
2011 32
2010 24
2009 31
2008 25
2007 13
2006 17
2005 22
2004 15
2003 6
2002 4
2001 8
2000 1
1999 2
1998 2
1997 4
1996 1
1995 1
1993 1
1990 4
1988 1
1987 1
1974 1
1973 1

Top Research Directions

Research directions most represented by papers from this venue.

Viscoelastic Monitoring of Whole Blood Coagulation 2
The Non-Additive Toxicity of Multi-Modal Adjunctive Therapies 2
Targeting the Mechanisms of Cancer Stem Cell Resistance 2
Overcoming Data Scarcity in Rare Disease Research 2
Transcriptional Artifacts and Selective Loss from Tissue Dissociation 1
Quantifying Clinical Relevance Beyond Statistical Significance 1
Molecular Clonal Tracking via Immune Repertoire Sequencing 1
Discovering Driver Pathways via Mutational Mutual Exclusivity 1
The Structural Convergence of Adaptive Immune Repertoires 1
Predicting Therapeutic Efficacy Before Morphological Change 1
Synergistic Innate Immune Activation via Combinatorial Adjuvants 1
Genetic Lineage Tracing for Mapping Cellular Ancestry 1
Mechanisms of Metabolic Drug-Drug Interactions 1
Bioorthogonal Labeling and Chemical Proteomics for Target Identification 1
The Dynamics of Dose Dependent Therapeutic Efficacy 1

Top Authors

AuthorPapers
Zhixiang Shen38
Jane E. Barker19
Hongyu An15
Barbara D. Lam12
Zinaida Good12
Mikel Hernaez11
Bita Sahaf9
Lori Muffly9
Matthew J. Frank9
James Nichols8
Jorge J. Nieva8
Allon M Klein7
Filippo Utro6
Jianqiang Li6
Kahn Rhrissorrakrai6
Meong Hi Son6
Moksha H. Desai6
Saurabh Dahiya6
Zachary Ehlinger6
Andrew R. Rezvani5

Impactful Papers

Papers from this venue that shaped research clusters.

Foundational

Influential

Related Venues

Venues with the most similar research cluster distributions.

Papers

TitleYear
Identification of Blut, a Novel Long-Noncoding RNA Differentially Expressed in Burkitt Lymphoma2015
Impaired Response to Influenza Vaccination in AML Patients Post-Chemotherapy Associated with a Highly Atypical B-Cell Profile2015
Increased Frequency of Cells with Activated Ribosomal Protein S6 at Diagnosis Associates with MRD Positivity and Relapse in Childhood BCP ALL2015
Neurocognitive, Psychosocial, and Quality of Life Outcomes in Adult Survivors of Childhood Non-Hodgkin Lymphoma in the St. Jude Lifetime (SJLIFE) Cohort2015
PD-1 Inhibits TCR Proximal Signaling By Sequestering SHP-2 Phosphatase and Facilitating Csk-Mediated Inhibitory Phosphorylation of Lck2015
PD-L1/CD80 and PD-L1/PD-1 Signaling Reciprocally Regulate Alloreactive CD8+ T Cell Glycolysis, Proliferation, Apoptosis and Gvhd-Inducing Capacity2015
Pegylated-Interferon Treatment Is Safe and Efficient for Pregnant Patients with Essential Thrombocythaemia2015
Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina2015
Prevention of Morbidity in Sickle Cell Disease (POMS 2): A Pilot Study of Nocturnal Respiratory Support Shows That Auto-Adjusting Positive Airways Pressure Is Safe and Is Preferred to Oxygen Therapy2015
Proteinuria Severity Is Directly Correlated with Markers of Hypofibrinolysis in a Podocyte Specific Experimental Model of Nephrotic Syndrome2015
RNA Sequencing Reveals Novel and Rare Fusion Transcripts in Acute Myeloid Leukemia2015
Safety and Response of Incorporating CD19 Chimeric Antigen Receptor T Cell Therapy in Typical Salvage Regimens for Children and Young Adults with Acute Lymphoblastic Leukemia2015
Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-Cell Acute Lymphoblastic Leukemia2015
TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution2015
Treatment Outcome and Prognostic Model for Stage IE/IIE Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Retrospective Study in a Cohort of 305 Patients with Long Term Follow-up2015
Use of Mathematical Modelling Indicates That Patients Treated for Acute Myeloid Leukaemia (AML) Are Undertreated When Ideal Body Weight Is Used to Dose Chemotherapy2015
von Willebrand factor is dimerized by protein disulfide isomerase2015
A Novel PI3K Inhibitor Identified By a High Throughput Virtual Screen Displays Potent Activity Against Multiple Myeloma2014
A Retrospective Analysis of Treatment Patterns in Elderly Patients with Chronic Myeloid Leukemia Receiving Dasatinib or Nilotinib As Second-Line Therapy after Imatinib2014
Comparison of Survival Rates, Healthcare Resource Use and Costs of Elderly Patients with Chronic Myeloid Leukemia Receiving Dasatinib or Nilotinib As Second-Line Therapy2014
Efficacy and Safety of Gemcitabine-Based Combination Regimens in Patients with Extranodal Natural Killer/T Cell Lymphoma, Nasal Type2014
End-Alveolar Carbon Monoxide As a Measure of Erythrocyte Survival and Hemolytic Severity in Sickle Cell Disease2014
Erratum2014
Genetic studies reveal an unexpected negative regulatory role for Jak2 in thrombopoiesis2014
Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans2014
High Resolution Mass Cytometry (CyTOF) in Aplastic Anaemia (AA) Can Identify an Aberrant Treg Subset with Pro-Inflammatory Properties, Predicting Poor Response to Immunosuppressive Therapy2014
Hodgkin’s Disease / Hodgkin-PTLD after Solid Organ Transplantation in Children: A Report on 16 Patients Treated According to Subsequent Gpoh-HD Treatment Schedules2014
Impact of Response Quality on Survival Outcomes in Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts): Results from the First Trial2014
In-Depth Quantitative Multiplex Proteomics Reveal Subtype-Specific Differences Among Functionally Validated AML Stem Cell Populations2014
Integrin αIIbβ3-Mediated c-Src Activation: Differential Binding to Inactive and Active c-Src2014
Intent-to-Treat Results of a Phase I Trial of CD19 Chimeric Antigen Receptor Engineered T Cells Using a Consistent Treatment Regimen Reveals a 67% Complete Response Rate in Relapsed, Refractory Acute 2014
In Vivo Methylome Changes in Purified Peripheral Blood Blasts and T Cells of AML Patients Treated with Decitabine: Statistical Modelling of a Hypomethylation Response2014
Longitudinal change in end-digit preference in blood pressure recordings of patients with hypertension in primary care clinics2014
Long-Term Complications after Splenectomy in Adult Chronic Immune Thrombocytopenia with a Minimum Follow up of 10 Years. First Results from a Single-Center Case-Control Study in 140 Patients with Prim2014
NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML2014
Ocular Complications of Bortezomib Therapy in Multiple Myeloma2014
Pre-Clinical Activity of the Novel, First-in-Class p97 Inhibitor, CB-5083, in Multiple Myeloma2014
Predicting First-Year Mortality in Incident Dialysis Patients with End-Stage Renal Disease - The UREA5 Study2014
Predictors of in-Hospital Mortality in Patients with Primary Central Nervous System Lymphoma2014
RPL27A Is a Target for Mir-595 and Contributes to Myelodysplastic Phenotype through Ribosomal Dysgenesis2014
Synergistic Lethal Effects Between Gemcitabine and Arsenic Trioxide on Non-Hodgkin Lymphoma Cell Lines Is Associated with Modulation of PI3K/Akt Signaling Pathway2014
The Identification of Further Minimal Regions of Overlap in Chronic Lymphocytic Leukemia Using High-Resolution SNP Arrays2014
Towards Response Prediction Using Integrated Genomics in Chronic Lymphocytic Leukaemia: Results on 250 First-Line FCR Treated Patients from UK Clinical Trials2014
Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival2013
Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia2013
A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency2013
A “non-fratricidal” αβ- T Cell Receptor That Targets Survivin Expressed By Hematological Malignancies2013
A Prognostic Score For Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation2013
A Sequential Two-Stage Dose Escalation Study Evaluating The Safety and Efficacy Of Eltrombopag In Thrombocytopenic Patients With Myelodysplastic Syndrome (MDS) Resistant To Hypomethylating Agents (HMA2013
Clot-On-A-Chip: A Microfluidic Device To Study Platelet Aggregation and Contractility Under Shear2013

« prev Page 13/19 next »